Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol

BACKGROUND: Acute respiratory distress syndrome (ARDS) in humans is caused by an unchecked proinflammatory response that results in diffuse and severe lung injury, and it is associated with a mortality rate of 35 to 45%. Mesenchymal stromal cells (MSCs; ‘adult stem cells’) could represent a promisin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lalu, Manoj M, Moher, David, Marshall, John, Fergusson, Dean, Mei, Shirley HJ, Macleod, Malcolm, Griffin, Gilly, Turgeon, Alexis F, Rudnicki, Michael, Fishman, Jason, Avey, Marc T, Skidmore, Becky, Grimshaw, Jeremy M, Stewart, Duncan J, Singh, Kavita, McIntyre, Lauralyn
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4046388/
https://ncbi.nlm.nih.gov/pubmed/24887266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-3-48
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares